BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 1715479)

  • 1. Sympathetic activity: modulator of myocardial hypertrophy.
    Long CS; Kariya K; Karns L; Simpson PC
    J Cardiovasc Pharmacol; 1991; 17 Suppl 2():S20-4. PubMed ID: 1715479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cardiac beta-myosin heavy chain isogene is induced selectively in alpha 1-adrenergic receptor-stimulated hypertrophy of cultured rat heart myocytes.
    Waspe LE; Ordahl CP; Simpson PC
    J Clin Invest; 1990 Apr; 85(4):1206-14. PubMed ID: 2156896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcription of early developmental isogenes in cardiac myocyte hypertrophy.
    Simpson PC; Long CS; Waspe LE; Henrich CJ; Ordahl CP
    J Mol Cell Cardiol; 1989 Dec; 21 Suppl 5():79-89. PubMed ID: 2560798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha 1-adrenergic receptor stimulation of sarcomeric actin isogene transcription in hypertrophy of cultured rat heart muscle cells.
    Long CS; Ordahl CP; Simpson PC
    J Clin Invest; 1989 Mar; 83(3):1078-82. PubMed ID: 2537847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sympathetic modulation of the cardiac myocyte phenotype: studies with a cell-culture model of myocardial hypertrophy.
    Long CS; Kariya K; Karns L; Simpson PC
    Basic Res Cardiol; 1992; 87 Suppl 2():19-31. PubMed ID: 1338564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of the skeletal alpha-actin gene in alpha 1-adrenoceptor-mediated hypertrophy of rat cardiac myocytes.
    Bishopric NH; Simpson PC; Ordahl CP
    J Clin Invest; 1987 Oct; 80(4):1194-9. PubMed ID: 2821075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trophic factors for cardiac myocytes.
    Long CS; Kariya K; Karns L; Simpson PC
    J Hypertens Suppl; 1990 Dec; 8(7):S219-24. PubMed ID: 1965655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renin-angiotensin system, hypertrophy and gene expression in cardiac myocytes.
    Lijnen P; Petrov V
    J Mol Cell Cardiol; 1999 May; 31(5):949-70. PubMed ID: 10336836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor I receptor signaling is required for exercise-induced cardiac hypertrophy.
    Kim J; Wende AR; Sena S; Theobald HA; Soto J; Sloan C; Wayment BE; Litwin SE; Holzenberger M; LeRoith D; Abel ED
    Mol Endocrinol; 2008 Nov; 22(11):2531-43. PubMed ID: 18801929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac hypertrophy induced by alpha- and beta-adrenergic receptor stimulation.
    Zimmer HG; Kolbeck-Ruhmkorff C; Zierhut W
    Cardioscience; 1995 Mar; 6(1):47-57. PubMed ID: 7605896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac myocyte hypertrophy is associated with c-myc protooncogene expression.
    Starksen NF; Simpson PC; Bishopric N; Coughlin SR; Lee WM; Escobedo JA; Williams LT
    Proc Natl Acad Sci U S A; 1986 Nov; 83(21):8348-50. PubMed ID: 3022291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SHP2 mediates gp130-dependent cardiomyocyte hypertrophy via negative regulation of skeletal alpha-actin gene.
    Nakaoka Y; Shioyama W; Kunimoto S; Arita Y; Higuchi K; Yamamoto K; Fujio Y; Nishida K; Kuroda T; Hirota H; Yamauchi-Takihara K; Hirano T; Komuro I; Mochizuki N
    J Mol Cell Cardiol; 2010 Aug; 49(2):157-64. PubMed ID: 20226789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelin-1-induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator-activated receptor-alpha partly via blockade of c-Jun NH2-terminal kinase pathway.
    Irukayama-Tomobe Y; Miyauchi T; Sakai S; Kasuya Y; Ogata T; Takanashi M; Iemitsu M; Sudo T; Goto K; Yamaguchi I
    Circulation; 2004 Feb; 109(7):904-10. PubMed ID: 14967736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inducible cAMP early repressor (ICER) is a negative-feedback regulator of cardiac hypertrophy and an important mediator of cardiac myocyte apoptosis in response to beta-adrenergic receptor stimulation.
    Tomita H; Nazmy M; Kajimoto K; Yehia G; Molina CA; Sadoshima J
    Circ Res; 2003 Jul; 93(1):12-22. PubMed ID: 12791704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. JunD attenuates phenylephrine-mediated cardiomyocyte hypertrophy by negatively regulating AP-1 transcriptional activity.
    Hilfiker-Kleiner D; Hilfiker A; Castellazzi M; Wollert KC; Trautwein C; Schunkert H; Drexler H
    Cardiovasc Res; 2006 Jul; 71(1):108-17. PubMed ID: 16690042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ouabain-induced hypertrophy in cultured cardiac myocytes is accompanied by changes in expression of several late response genes.
    Huang L; Li H; Xie Z
    J Mol Cell Cardiol; 1997 Feb; 29(2):429-37. PubMed ID: 9140803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catecholamines in cardiac hypertrophy.
    Scheuer J
    Am J Cardiol; 1999 Jun; 83(12A):70H-74H. PubMed ID: 10750591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross talk between corticosteroids and alpha-adrenergic signalling augments cardiomyocyte hypertrophy: a possible role for SGK1.
    Lister K; Autelitano DJ; Jenkins A; Hannan RD; Sheppard KE
    Cardiovasc Res; 2006 Jun; 70(3):555-65. PubMed ID: 16533503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective activation of alpha1A-adrenergic receptors in neonatal cardiac myocytes is sufficient to cause hypertrophy and differential regulation of alpha1-adrenergic receptor subtype mRNAs.
    Autelitano DJ; Woodcock EA
    J Mol Cell Cardiol; 1998 Aug; 30(8):1515-23. PubMed ID: 9737938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenergic pathways and left ventricular remodeling.
    Dorn GW
    J Card Fail; 2002 Dec; 8(6 Suppl):S370-3. PubMed ID: 12555147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.